Catalyst Wire Dossier Catalyst Wire Dossier

Nidufexor

Nidufexor · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nidufexor, covering 2022-06-29 to 2022-06-29. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Efficacy of Nidufexor in Patients With Diabetic Nephropathy [Phase 2]

See pricing